![Michael Sumner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 46 242 $ au 30/06/2026
Michael Sumner is currently Chief Medical Officer & Head-Development at Inovio Pharmaceuticals, Inc. since 2022 and a Member of The Royal College of Physicians.
Former roles include Senior Director-Medical Affairs at Aventis Behring, Executive Director-Medical Affairs at Novo Nordisk Pharmaceuticals Pty Ltd., Vice President-Clinical & Medical Affairs at Shire Regenerative Medicine, Inc., Medical Manager at Novartis Pharmaceuticals UK Ltd., and Chief Medical Officer at Orexo AB from 2013 to 2022.
Education includes a doctorate from the University of London and an MBA from Henley Management College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 42 038 ( 0,05 % ) | 46 242 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 27/06/2022 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| OREXO AB | Directeur Technique/Scientifique/R&D | 26/10/2022 |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Directeur Technique/Scientifique/R&D | - |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Directeur Technique/Scientifique/R&D | - |
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Directeur Technique/Scientifique/R&D | - |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Henley Management College
 Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk Pharmaceuticals Pty Ltd.
Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
